Cortical Excitation:Inhibition Imbalance Causes Abnormal Brain Network Dynamics as Observed in Neurodevelopmental Disorders by Markicevic, Marija et al.








Cortical Excitation:Inhibition Imbalance Causes Abnormal Brain Network
Dynamics as Observed in Neurodevelopmental Disorders
Markicevic, Marija ; Fulcher, Ben D ; Lewis, Christopher ; Helmchen, Fritjof ; Rudin, Markus ; Zerbi,
Valerio ; Wenderoth, Nicole
Abstract: Abnormal brain development manifests itself at different spatial scales. However, whether ab-
normalities at the cellular level can be diagnosed from network activity measured with functional magnetic
resonance imaging (fMRI) is largely unknown, yet of high clinical relevance. Here a putative mechanism
reported in neurodevelopmental disorders, that is, excitation-to-inhibition ratio (E:I), was chemogenet-
ically increased within cortical microcircuits of the mouse brain and measured via fMRI. Increased E:I
caused a significant ”reduction” of long-range connectivity, irrespective of whether excitatory neurons
were facilitated or inhibitory Parvalbumin (PV) interneurons were suppressed. Training a classifier on
fMRI signals, we were able to accurately classify cortical areas exhibiting increased E:I. This classifier was
validated in an independent cohort of Fmr1y/- knockout mice, a model for autism with well-documented
loss of parvalbumin neurons and chronic alterations of E:I. Our findings demonstrate a promising novel
approach towards inferring microcircuit abnormalities from macroscopic fMRI measurements.
DOI: https://doi.org/10.1093/cercor/bhaa084






The following work is licensed under a Creative Commons: Attribution-NonCommercial 4.0 International
(CC BY-NC 4.0) License.
Originally published at:
Markicevic, Marija; Fulcher, Ben D; Lewis, Christopher; Helmchen, Fritjof; Rudin, Markus; Zerbi, Vale-
rio; Wenderoth, Nicole (2020). Cortical Excitation:Inhibition Imbalance Causes Abnormal Brain Network
Dynamics as Observed in Neurodevelopmental Disorders. Cerebral Cortex, 30(9):4922-4937.
DOI: https://doi.org/10.1093/cercor/bhaa084
© The Author(s) 2020. Published by Oxford University Press.
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/
licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
For commercial re-use, please contact journals.permissions@oup.com
Cerebral Cortex, September 2020;30: 4922–4937
doi: 10.1093/cercor/bhaa084
Advance Access Publication Date: 21 April 2020
Original Article
OR I G INAL ART I C L E
Cortical Excitation:Inhibition Imbalance Causes
Abnormal Brain Network Dynamics as Observed in
Neurodevelopmental Disorders
Marija Markicevic1,2, Ben D. Fulcher3, Christopher Lewis4,
Fritjof Helmchen2,4, Markus Rudin2,5,6, Valerio Zerbi 1,2,† and
Nicole Wenderoth1,2,†
1Neural Control of Movement Lab, HEST, ETH Zürich, 8093 Zurich, Switzerland, 2Neuroscience Center Zurich,
University and ETH Zurich, 8057 Zurich, Switzerland, 3School of Physics, The University of Sydney, NSW 2006,
Australia, 4Brain Research Institute, University of Zurich, 8057 Zurich, Switzerland, 5Institute of Pharmacology
and Toxicology, University of Zurich, 8057 Zurich, Switzerland and 6Institute for Biomedical Engineering,
University and ETH Zurich, 8093 Zurich, Switzerland
Address correspondence to Dr Valerio Zerbi, Neural Control of Movement Lab, Department of Health Sciences and Technology, Auguste-Piccard-Hof 1,
ETH Zürich, 8093 Zurich, Switzerland. Email: valerio.zerbi@hest.ethz.ch.
†V.Z. and N.W. share last authorship.
Abstract
Abnormal brain development manifests itself at different spatial scales. However, whether abnormalities at the cellular
level can be diagnosed from network activity measured with functional magnetic resonance imaging (fMRI) is largely
unknown, yet of high clinical relevance. Here a putative mechanism reported in neurodevelopmental disorders, that is,
excitation-to-inhibition ratio (E:I), was chemogenetically increased within cortical microcircuits of the mouse brain and
measured via fMRI. Increased E:I caused a significant “reduction” of long-range connectivity, irrespective of whether
excitatory neurons were facilitated or inhibitory Parvalbumin (PV) interneurons were suppressed. Training a classifier on
fMRI signals, we were able to accurately classify cortical areas exhibiting increased E:I. This classifier was validated in an
independent cohort of Fmr1 y/− knockout mice, a model for autism with well-documented loss of parvalbumin neurons and
chronic alterations of E:I. Our findings demonstrate a promising novel approach towards inferring microcircuit
abnormalities from macroscopic fMRI measurements.
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Introduction
Complex behavior results from the interplay of distributed
yet anatomically connected neuronal populations which form
brain-wide networks. Abnormal brain development as in
autism spectrum disorders (ASD) often affects the structural
and functional connectivity (FC) within these networks at
different spatial scales: at the cellular and (micro)circuit levels,
neurodevelopmental disorders are associated with dysregulated
synaptogenesis, cell excitability, synaptic transmission, and
plasticity (Penagarikano et al. 2011; Bulow et al. 2019), as well as
aberrant axonal migration and abnormal functioning of cortical
(micro)circuits (Contractor et al. 2015); at the network level,
long-range functional connectivity and macroscopic neuronal
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Mechanistically linking disease mechanisms across scales is
an important goal for neuropsychiatry, particularly, to identify
whether certain cellular disease pathways map onto specific
alterations of large-scale network activity, which are accessible
in human patients and might thus allow to infer the underlying
pathobiology of an individual patient.
An abnormal increase of the excitation-to-inhibition (E:I)
ratio within specific cortical circuits (Rubenstein and Merzenich
2003) has been hypothesized as a putative disease mechanism
underlying ASD pathology and its core behavioral symptoms
(Silverman et al. 2010; Kazdoba et al. 2014). In transgenic
mouse models of ASD, elevated E:I has been observed either
because excitatory transmission is increased (Gibson et al. 2008)
or because inhibitory transmission is reduced, for example,
due to the loss of fast-spiking parvalbumin (PV) GABAergic
interneurons (Penagarikano et al. 2011; Wohr et al. 2015;
Vogt et al. 2017). However, it is unknown whether such an
imbalance at the microcircuit level propagates across scales
and whether macroscopic markers of brain activity signal these
abnormalities with anatomical specificity.
Here we acutely increase microcircuit E:I within one brain
region and test whether this well-controlled manipulation
causes an anatomically specific change of neuronal dynamics
and macroscopic connectivity of the mouse brain. We used
chemogenetics (Rogan and Roth 2011; Michaelides and Hurd
2016) to manipulate cell activity of primary somatosensory
cortex (SSp) while simultaneously imaging brain activity
using resting-state functional magnetic resonance imaging
(rsfMRI). rsfMRI is a noninvasive method used to measure
spontaneous slow-frequency fluctuations of the blood-oxygen
level-dependent (BOLD) signal (an indirect estimate of neuronal
activity) in the absence of a task and across the entire brain
(Fox and Raichle 2007). A growing body of evidence suggests
that rsfMRI has great potential for translation, as it detects
abnormalities in long-range network correlations in human
patients as well as homologous networks in mouse models
expressing similar transgenic mutations (Strand et al. 2007;
Smucny et al. 2014; Shofty et al. 2019). Here, we show that
experimentally increasing E:I in primary somatosensory cortex
(SSp) by either 1) facilitating excitatory neurons or 2) suppressing
inhibitory PV interneurons both caused a reduction of long-
range functional connectivity between SSp and anatomically
connected areas. Increasing E:I changed the dynamics of
BOLD fluctuations, an effect that was most pronounced in the
targeted SSp. We used the BOLD time series measured during
experimentally controlled chemogenetic suppression of PV
interneurons to train a classifier to detect acutely overexcited
brain areas. We applied this classifier to an independent
cohort of Fmr1y/− knockout mice, a well-characterized model
for ASD (Haberl et al. 2015; Zerbi et al. 2018) which suffers
from PV interneuron depletion and exhibits increased cortical
E:I due to the loss of inhibitory inputs (Antoine et al. 2019).
Importantly, the classifier identified specific brain regions
in somatosensory and prefrontal cortices which exhibited
an overexcitation phenotype based on their BOLD dynamics.
This new finding indicates that chemogenetically perturbing
microcircuit abnormalities in wild-type mice allows us to build
“computational sensors” for detecting E:I imbalances from
noninvasive macroscopic rsfMRI measurements in a disease
model. Our results demonstrate a promising novel approach
toward inferring microcircuit abnormalities from macroscopic
measurements which potentially opens new opportunities for
investigating disease mechanisms across species.
Materials and Methods
All experiments and procedures were conducted following
the Swiss federal ordinance for animal experimentation and
approved by Zurich Cantonal Veterinary Office (ZH238/15).
C57BL/6J mice were obtained from Charles River Laboratories
(Germany), while Pvalbtm1(cre)Arbr (PVCre) mice were derived
from in-house breeding (first generation obtained from the
Jackson Laboratory). All mice were kept in standard housing
under 12-h light/dark cycle with food and water provided ad
libitum throughout the whole experiment. A total of 29 male
C57BL/6J mice were used in the experiment, aged 9±1 weeks
and weighing 25.1± 1.8 g (mean± standard deviation [SD]) at
the day of the surgery. A total of 19 PVCre mice were utilized in
this experiment, aged 11± 1.6 weeks and weighing 26.1±3.8 g
at the day of the surgery.
Procedures for Wild-Type (hM3Dq) Mice Study
Transfection Procedures for “wt-hSyn-hM3Dq” and
“wt-CAMK-hM3Dq” Mice
Each mouse was initially anesthetized using a mixture of mida-
zolam (5 mg/mL; Sintetica, Switzerland), fentanyl (50 mcg/mL;
Actavis AG, Switzerland), and medetomidine (1 mg/mL; Orion
Pharma, Finland). Upon anesthesia induction, mice were placed
on a heating pad, and the temperaturewas kept at 35 ◦C (Harvard
Apparatus, United States). Following shaving and cleaning,
an incision along the midline of scalp was made. The right
primary somatosensory cortex was targeted at the coordinates
of +0.5 mm AP (anterior–posterior), −3.0 mm ML (medio–
lateral), and −2.25 mm DV (dorso–ventral) relative to bregma
using a drill and microinjection robot (Neurostar, Germany)
with a 10-ul NanoFil syringe and 34-G beveled needle (World
Precision Instruments, Germany). Nine hundred fifty nanoliters
of ssAAV8-hSyn-hM3Dq-mCherry (n=13) of a physical titer
≥5.4×1012 vg/mL (∗vector genomes; fluorometric quantifica-
tion) was injected at the rate of 0.06 ul/min. The virus was
provided by Viral Vector Core Facility of the Neuroscience Centre
Zurich (http://www.vvf.uzh.ch/en.html). Upon the injection, the
needle was left in place for 10 min and then slowly withdrawn.
C57BL/6J control mice (n=9) underwent the same surgical
procedures, where the needle was kept in place for 5 min but
without any viral injections. Subsequently, mice were given an
anesthesia antidote consisting of Temgesic (0.3 mg/mL; Reckitt
Benckiser AG, Switzerland), annexate (0.1 mg/mL; Swissmedic,
Switzerland), and antisedan (0.1 mg/mL; Orion Pharma, Finland)
and left to fully recover. Following the surgery, ketoprofen
(10 mg/kg; Richter Pharma AG, Austria) was subcutaneously
injected daily for at least 3 days to reduce any postoperative
pain. Animals were given 3–4 weeks to fully recover from the
surgery and to allow for expression of the transgene prior to the
scanning session.
Another cohort of 13 C57BL/6J mice was injected with
950 nL of ssAAV8-mCAMKIIα-hM3D-mCherry of a physical titer
≥1.8×1012 vg/mL following identical procedures as outlined
above. Supplementary Figure 7 illustrates the extension of viral
expression at the targeted region.
Electrophysiological Recordings
The electrophysiological data used for verification of neuronal
activity were acquired in four wt-hSyn-hM3Dq animals and
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receptor exclusively activated by designer drug (DREADD) injec-
tion, that is, controls. Briefly, animals were anesthetized with
isoflurane to match conditions used in imaging studies (2–4%
for induction, 0.5% for data collection), and their body tem-
perature was maintained using a heating pad. A small cran-
iotomy was performed over the right and left somatosensory
cortices, and the brain was covered with silicone oil. A small
trepanation was performed over the cerebellum, and a silver
wire was placed in contact with the CSF to serve as refer-
ence electrode. For hM3Dq validation, one silicone probe (Atlas
Neurotechnologies; E16-100-S1-L6NT, 16 sites, 100-μm spacing,
iridium oxide contacts) was implanted in each hemisphere.
After implantation, we waited 20–30 min in order to allow the
recording to stabilize. After stabilization, the broadband voltage
was amplified and digitally sampled at a rate of 30 kHz or
48 kHz using one of the two commercial extracellular recording
systems (Intan or Axona). The raw voltage traces were filtered
off-line in order to separate the multiunit activity (MUA) (band-
pass filter 0.46–6 kHz) using a second-order Butterworth fil-
ter. Subsequently, for each electrode, a threshold was applied
to the high-pass filtered data to isolate multiunits and reject
background noise (4.5 times the standard deviation across the
recording session, specified per electrode). The number of spikes
was counted in 10-s windows. As an additional control, we low-
ered the detection threshold which did not change the results,
unless it was decreased below the background noise. Recording
sessions lasted for 45 min. At 15 min following the start of the
recordings (“baseline”) 30-μg/kg clozapine was injected (intra-
venously). In order to combine data across mice, the activity at
sites with clear multiunit activity was expressed in percent of
the baseline value, that is, each 10-s bin of MUA activity was
divided by the average spike rate during the 15-min preinjection
baseline (100%). All multiunits were then combined from the
injected or control region.
MRI Setup and Animal Preparation
TwoMRI sessions were performed on a 7-T Bruker BioSpec scan-
ner equipped with a PharmaScan magnet, with two coil setups
optimized for the two different acquisition sequences, that is,
arterial spin labeling (ASL) and resting-state fMRI (rsfMRI). First,
the ASL was obtained utilizing a receiver-only surface coil, cou-
pled with a volume resonator for radio-frequency (rf) trans-
mission. For rsfMRI measurements, a high signal-to-noise ratio
(SNR) receive-only cryogenic coil (Bruker BioSpin AG, Fällanden,
Switzerland) was used in combination with a linearly polarized
room temperature volume resonator for rf transmission.
Standardized anesthesia protocols and animal monitoring
procedures were utilized for bothMRI sessions (Zerbi et al. 2018).
Briefly,micewere initially anesthetizedwith 4% isoflurane in 1:4
O2 to air mixture for 4 min to allow for endotracheal intubation
and tail vein cannulation. Mice were positioned on an MRI-
compatible support, equipped with hot water-flowing bed to
keep the temperature of the animal constant throughout the
entire measurement (36.6± 0.5 ◦C). The animals were fixed with
ear bars and mechanically ventilated via a small animal venti-
lator (CWE, Ardmore, United States) at the rate of 80 breaths per
min, with 1.8-mL/min flow with isoflurane at 2%. Subsequently,
a bolus containing a mixture of medetomidine (0.05 mg/kg) and
pancuronium (0.25 mg/kg) was injected via the cannulated vein
and isoflurane lowered at 1%. Five minutes following the bolus
injection, a continuous infusion of medetomidine (0.1 mg/kg/h)
and pancuronium (0.25 mg/kg/h) was started while isoflurane
was further reduced to 0.5%.Animal preparation took on average
15.5± 2.7min and all animals fully recoveredwithin 10min after
the measurement.
Arterial Spin Labeling (ASL)
Brain perfusion was measured using an established arterial
spin labeling (ASL) method using a flow-sensitive alternating
inversion recovery (FAIR) sequence (Leithner et al. 2008;
Zerbi et al. 2014). Briefly, a two-segment spin echo was
used with following parameters: echo time (TE) = 12.47 ms,
recovery time (TR) = 13 000 ms, image matrix = 128×96, field
of view=20×20 mm, slice thickness=1 mm, and spatial
resolution=0.156×0.208×1 mm/pixel. Inversion parameters
include inversion time=40 ms, inversion slab thickness=4 mm,
and slice margin=1.5 mm. Sixteen images at different inversion
times (50 ms to 3 s) were obtained for T1 calculations, resulting
in a scan time of 15 min (referred to as “baseline”). After the
first baseline acquisition, clozapine was intravenously injected
at 10–30 μg/kg, and three more sessions were acquired (i.e., Post
1, Post 2, and Post 3, respectively), resulting in a total scan time of
1 h. A total of 26 animals (5 controls, 8 wt-hM3Dq, and 13 CAMK-
hM3Dq mice) were scanned. Due to a subjective placement of
a 1-mm-thick slice over the somatosensory cortex prior to the
scan start, theremay be slight differences across subjects in slice
position relative to the bregma. However, we made sure that
every brain slice of every subject covered virally transfected SSp.
Local changes in cerebral blood flow (CBF) could be consid-
ered as an indirect marker of neural activity (Juepter andWeiller
1995). Taking this into account, CBF is expected to increase
at the site of DREADD injection, where we observed strongest
increases in firing rates, but not elsewhere.We chose our regions
of interest (ROIs) based on this analogy, and they included (i)
right primary somatosensory cortex (SSp), as a DREADD injec-
tion site (main region of interest); (ii) left primary somatosen-
sory cortex, as an anatomically connected region; and (iii) left
striatum (dorsomedial part) (CP), a control region without any
anatomical projections to the right primary somatosensory area,
according to Allen Mouse Connectivity Atlas (Oh et al. 2014).
Resting-State fMRI (rsfMRI)
Acquisition parameters were the following: repetition time
(TR) = 1 s, echo time (TE) = 15 ms, flip angle = 60◦, matrix
size=90×50, in-plane resolution=0.2×0.2 mm2, number of
slices = 20, slice thickness=0.4 mm, and 3600 volumes for a total
scan of 60 min. Clozapine was intravenously injected 15 min
after the scan start at the doses of 10 μg/kg or 30 μg/kg. A total
of 40 C57BL/6J animals (13 controls and 14 wt-hM3Dq and 13
CAMK-hM3Dqmice) were scanned.These include eight C57BL/6J
animals that were scanned twice (four controls and four wt-
hM3Dqmice), once with 10 μg/kg dose of clozapine and another
with a 30 μg/kg dose of clozapine (Supplementary Table 1 and
Supplementary figure 8).
Data Preprocessing. Data was preprocessed using an already
established pipeline for removal of artifacts from the time
series (Zerbi et al. 2015; Sethi et al. 2017). Briely, each 4D
dataset was normalized in a study-specific EPI template
(Advanced Normalization Tools [ANTs] v2.1, picsl.upenn.e
du/ANTS) and fed into MELODIC (Multivariate Exploratory
Linear Optimized Decomposition into Independent Com-
ponents) to perform within-subject spatial independent
component analysis (ICA) with a fixed dimensionality esti-
mation (number of components set to 60). The procedure
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0.3-mm kernel. FSL-FIX study-specific classifier, obtained from
an independent dataset of 15 mice, was used to perform
a “conservative” removal of the variance of the artifactual
components (Griffanti et al. 2014). Subsequently, the dataset
was despiked, band-pass filtered (0.01–0.25 Hz), and finally
normalized into Australian Mouse Brain Mapping Consortium
(AMBMC) template (www.imaging.org.au/AMBMC) using ANTs.
The choice of our band-pass filter is based on the recent
literature where it is stated that the frequency distribution of
the fMRI signal yields the maximum amplitude between 0.1 Hz
and 0.2 Hz under medetomidine anesthesia (Pan et al. 2013;
Grandjean et al. 2014). Each dataset was split into 4 parts of 900
data points (equivalent of 15 min of scanning). The difference
between the baseline (first 15 min of scan) and the rest of the
bins are further referred to as 1, 2, and 3.
Seed-to-Seed Analysis. The “somatosensory network” in the
mouse was defined anatomically using the tracer-based
axonal projection pattern of SSp from the Allen Mouse Brain
Connectivity Atlas (experiment No. 114290938) and contained
contralateral primary SSp, right supplementary somatosensory
area (SSs), bilateral somatomotor area (MO), bilateral temporal
association cortices (TEa), as well as ipsilateral caudoputamen
(CP) and thalamus (TH [parafascicular nucleus]) (Grandjean et al.
2017). BOLD time series from these regions, apart from thalamus,
were extracted using a voxel cube of 3 mm. The thalamus was
excluded because a previous study from our lab has shown a
rather limited FC of corticothalamic pathways (Grandjean et al.
2017) detected by rsfMRI. Correlation Z-scored matrices were
calculated using FSLNets (FMRIB Analysis Group).
Regional Homogeneity (ReHo). Voxel-wise regional homogeneity
(ReHo) maps were computed using AFNI. ReHo was calculated
for a given voxel and its 19 nearest neighbors and smoothened
by Gaussian kernel with full width at half maximum (FWHM)
equal to 10.
Voxel-Mirrored Homotopic Connectivity (VMHC). VMHC measures
the similarity between any pair of symmetric interhemispheric
voxels by computing Pearson’s correlation coefficient between
the time series of each voxel and that of its exact symmetrical
interhemispheric counterpart. VMHC was computed for all the
four time-series bins and normalized to the baseline for each
mouse.
Functional Connectome Analysis. Whole-brain correlation matri-
ces were obtained from a parcellation scheme of 130 regions
using the Allen Mouse Brain ontology (Oh et al. 2014). In total,
65 regions of interest (ROIs) per hemisphere were considered,
including regions from the isocortex, hippocampal formation,
cortical subplate, striatopallidum, thalamus, midbrain, and
hindbrain. Cohen’s d effect size was calculated, using the time
series obtained from these whole-brain correlation matrices.
Statistical Analysis. Prior to performing statistical tests, within-
subject normalization to the baseline was implemented. FSL
general linear model (GLM) was used to perform statistical com-
parison between controls and wt-hM3Dq mice for the rsfMRI
data (including seed-to-seed analysis, ReHo, VMHC, connec-
tome analysis). We performed nonparametric permutation test-
ing with 5000 permutations, using family-wise error correction
with threshold-free cluster enhancement (TFCE). Statistical sig-
nificance was defined as P<0.05. CBF differences were statisti-
cally tested using linear mixed models implemented in SPSS24
(IBM, United States). In order to account for possible within-
subject variance during scan preparation, all the statistical anal-
ysis included six covariates: 1) mouse age at the time of surgery;
2) bodyweight at the time of the scan; 3) total scan preparation
time, that is, the time between the first anesthesia induction to
the start of the resting-state scan; 4) bolus time, that is, the time
from the bolus injection to the start of the continuous anesthetic
infusion (isoflurane at 0.5%); 5) the number of ICA components
rejected using FSL-FIX; and 6) clozapine dose. These covariates
were implemented in all the statistical tests for all types of
analysis performed.
Procedures for PVCre (hM4Di) Mice Study
Transfection Procedures for “PVCre-hSyn-hM4Di” Mice
The right primary somatosensory cortex of PVCre mice
(mice expressing Cre recombinase in parvalbumin-expressing
neurons) was unilaterally targeted with 950 nL of ssAAV8-
hSyn1-dlox-hM4Di-mCherry(rev)-dlox-WPRE-hGHp(A) (n=19) of
a physical titer≥5.4×1012 vg/mL (∗vector genomes; fluorometric
quantification) at the rate of 0.06 μL/min. The same procedures
for animal preparation, anesthesia, and coordinates were used
as already described for wild-type mice.
In Vivo Electrophysiology
Four PVCre-hSyn-hM4Di mice underwent in vivo electrophysio-
logical recordings following the same procedures as described
for wild-type mice (see Electrophysiological Recordings). The
only difference was in the location of the control probe (Atlas
Neurotechnologies, E32-100-S1-L6NT, 32 sites, 100-μm spacing,
iridium oxide contacts), which was implanted into the right
(ipsilateral to the DREADD injection site) striatum.
RsfMRI Acquisition
Preparation and anesthesia used for the scanning of the PVCre-
hSyn-hM4Di mice were identical to the procedures outlined for
wild-typemice (seeMRI Setup and Animal Preparation). The two
acquisitions only differed in the length of the scan. The PVCre-
hSyn-hM4Dimicewere scanned for 45minwhere clozapinewas
intravenously injected at 15 min at the dose of 30 mg/mL.
Classification of Univariate BOLD Time Series
Note that all code for analysis of univariate BOLD dynamics can
be found at https://github.com/benfulcher/hctsa_DREADD.
Data Processing and Feature Computation
We analyzed univariate BOLD time series measured from
three brain regions: 1) right SSp (injected region); 2) left SSp
(contralateral region); and 3) visual cortex (control region). Time-
series measurements were split into three 15-min durations
and labeled according to four classes of experiments: 1) wt-
hSyn-hM3Dq (14 mice); 2) wt-CAMK-hM3Dq (13 mice); 3) PVCre-
hSyn-hM4Di (19 mice); and 4) “sham” controls (13 mice). To
understand which time-series properties distinguish different
experimental conditions, we converted each univariate time
series to a vector of 7873 interpretable properties (or features)
using v0.9.6 of the hctsa toolbox (Fulcher et al. 2013; Fulcher
and Jones 2017). This toolbox contains implementations of
time-series features developed across different scientific
disciplines, including summaries of the distribution of values
in the data; its autocorrelation structure; stationarity, entropy,
and predictability; parameters and goodness of time-series
model fits; and methods from the physical nonlinear time-
series analysis literature (see Fulcher and Jones, 2017, for
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were then represented as a 108 (experiments)×7873 (time-
series features) data matrix. Features with well-behaved,
real-numbered outputs across the whole dataset and were
nonconstant within all the three groups were retained for
further analysis (7279 features). Each time series was labeled by
its experimental condition (wt-hSyn-hM3Dq, wt-CAMK-hM3Dq,
PVCre-hSyn-hM4Di, or sham) and time-point (baseline, “t2,”
and “t3”).
Classification
We used the feature-based representations of BOLD time series
in each brain area as the basis for classifying the different
experimental conditions. We focused our analysis on the 1
time period, first subtracting time-series features computed
at baseline and then normalizing these feature differences
using an outlier-robust sigmoidal transformation (Fulcher et al.
2013). A linear support vector machine classification model was
learned on the normalized feature matrix for a given brain area,
using inverse probability class reweighting to accommodate
class imbalance. A measure of discriminability of a pair of
classes was quantified as the balanced classification accuracy
using 10-fold stratified cross-validation. Balanced accuracy was
computed as the arithmetic mean of sensitivity and specificity
to account for the small class imbalance: 13 sham controls and
14 wt-hSyn-hM3Dq or 13 wt-CAMK-hM3Dq or 19 PVCre-hSyn-
hM4Di mice. To reduce variance in the random partition of data
into 10 folds, we repeated this procedure 50 times (with each
iteration yielding a balanced accuracy value) and summarized
the resulting distribution of balanced accuracies as its mean
and standard deviation.
In smaller samples, there is a greater probability that opti-
mistic classification results can be obtained by chance. To quan-
tify this, we evaluated the statistical significance of our classi-
fication results relative to random assignments of class labels
to data. This was achieved by computing a null distribution
of the same performance metric used above (mean across 50
repeats of 10-fold cross-validated balanced accuracy) for 5000
random class label assignments to time series. The statistical
significance of a given classification result was then estimated
as a permutation test (as the proportion of 5000 null samples
with a mean balanced classification rate exceeding that of the
true assignment of class labels).
Low-Dimensional Projections
As explained above, each BOLD signal was represented as a
feature vector or, equivalently, as a point in a high-dimensional
feature space. To aid the visualization of the class structure of
data in this space,we projected normalized time series× feature
data matrices into a lower-dimensional space that captures
the maximal variance in the full feature space using principal
component analysis. In these plots, individual time series are
points in the space, providing an intuitive visualization of the
structure of the time-series dataset.
Interpreting Differences in Univariate Dynamics
We aimed to determine which properties of the univariate BOLD
dynamics in the injected brain area best discriminated 1) wt-
hSyn-hM3Dq from controls; 2) wt-CAMK-hM3Dq from controls;
3) PVCre-hSyn-hM4Di from controls; and 4) wt-hSyn-hM3Dq
from wt-CAMK-hM3Dq and also from PVCre-hSyn-hM4Di mice.
Focusing on the first time period after baseline, we first com-
puted the difference in each feature value between this first time
period and the baseline period (1). We then tested whether
these relative feature values differed between groups using a
Wilcoxon rank-sum test. Statistical correction for the large num-
ber of hypothesis tests was performed as the false discovery rate
(Benjamini and Hochberg 1995), setting a significance threshold
of q=0.05.
Predicting Fmr1y/− Mice Using a Classifier Trained on
PVCre-hSyn-hM4Di
Time series from 46 cortical ROIs (23 in each hemisphere)
obtained from Fmr1y/− (n=44) and wild-type littermates (n=39)
was obtained from 2 of our previous studies (Zerbi et al.
2018; Zerbi et al. 2019b). The classification proceeded in two
stages. In the training phase, a classification model was trained
on normalized features of rsfMRI time series in SSp (right
hemisphere) during the 1 time period, as described above.
That is, the trained classifier learns features of the BOLD
dynamics to accurately predict whether a new time series is
PVCre-hSyn-hM4Di or control. In the testing phase, the trained
model was used to predict labels of rsfMRI time series in Fmr1y/−
dataset. We identified PVCre-hSyn-hM4Di with the Fmr1y/−
knockout condition and quantified prediction performance as
balanced accuracy (%) as above, evaluated in each brain region
independently. P values were estimated for each brain area
using permutation testing with 5×106 null samples generated
by independent shuffling of labels and corrected across brain
regions (focusing just on the right hemisphere) using the false
discovery rate method of Benjamini and Hochberg (Benjamini
and Hochberg 1995).
Histological Evaluation of Transfection
DREADD’s viral expression (for wt-hSyn-hM3Dq, PVCre-hSyn-
hM4Di, and wt-CAMK-hM3Dq) was confirmed by mCherry
staining using standard immunohistochemistry protocols.
Briefly, after the lastMRI session,micewere deeply anesthetized
using a mixture of ketamine (100 mg/kg; Graeub), xylazine
(10 mg/kg; Rompun, Bayer), and acepromazine (2 mg/kg; Fatro
S.p.A) and transcardially perfused with 4% paraformaldehyde
(PFA, pH=7.4). The brains were postfixed in 4% PFA for 1.5 h
at 4 ◦C and then placed overnight in 30% sucrose solution.
Brains were frozen in a tissue mounting fluid (Tissue-Tek
O.C.T Compound, Sakura Finetek Europe B.V.) and sectioned
coronally in 40-μm-thick slices using a cryostat (MICROM
HM 560, Histocom AG, Switzerland). Free-floating slices were
first permeabilized in 0.2% Triton X-100 for 30 min and then
incubated overnight in 0.2% Triton X-100, 2% normal goat
serum, and rabbit anti-mCherry (1:1000, Ab167453, Abcam)
at 4 ◦C under continuous agitation (100 rpm/min). The next-
day sections were incubated for 1 h in 0.2% Triton X-100, 2%
normal goat serum, goat antirabbit Alexa Fluor 546 (1:300,
A11035, Life Technologies), and Nissl (1:300, NeuroTrace 660,
Thermo Molecular Probes) or DAPI (1:300, Sigma-Aldrich) at
room temperature under continuous agitation. Afterward,
slices were mounted on the SuperFrost slides where they were
left to air-dry and later coverslipped with Dako Fluorescence
mounting medium (Agilent Technologies). Confocal laser-
scanning microscope (Leica, SP8, Center for Microscopy and
Image Analysis, UZH) and Zeiss Slide Scanner (Zeiss Axio scan,
Z1, Center for Microscopy and Image Analysis, UZH) were used
to detect the viral expression. Microscopy protocol included a
tile scan with a 10× or a 20× objective, a pixel size of 1.2 μm, and
an image size of 1024× 1024 pixels. Images were preprocessed
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Results
The E:I balance was experimentally increased in the right SSp
(Supplementary Figure 1). Adult mice were transfected with
excitatory designer receptors exclusively activated by designer
drugs (hM3Dq DREADDs), which were tuned to primarily target
pyramidal neurons (wt-CAMK-hM3Dq and wt-hSyn-hM3Dq,
n=13; n=10). Control mice were sham operated (weight-
and age-matched littermate controls, n=9; Supplementary
Table 1). Three to four weeks after surgery, mice were lightly
anesthetized, and electrophysiology or macroscopic brain
activity was recorded before and after activating the DREADDs
with a low dose of clozapine.
In vivo electrophysiology recordings in wt-hSyn-hM3Dq
mice, used primarily to ensure successful DREADD activation,
confirmed that activating the DREADDs increases net excitation
within the targeted right SSp but not in a control area, that
is, its homotopic counterpart (left SSp). Multiunit activity was
recorded under isoflurane anesthesia (0.5%) from multicontact
electrode arrays (Fig. 1A–D). During the baseline period (15 min),
the average basal firing rate was stable in both brain areas.
However, upon clozapine injection, the average firing rate in
the right SSp increased steadily over time while activity in
the left SSp remained virtually unchanged. Thirty minutes
after injection, the difference in averaged multiunit activity
between left and right SSp reached 11% (Fig. 1A–D). We further
investigated the effects of clozapine on neuronal activity inmice
that did not express DREADDs. With clozapine injection, the
average firing rate in the right SSp as well as in a control region
remained unchanged (Supplementary Figure 2). This suggests
that clozapine administered at our concentration has no effect
on neuronal activity in the absence of DREADD.
Next, we used noninvasive fMRI to test whether activation of
hM3Dq-DREADD in wt-hSyn-hM3Dq would elicit anatomically
specific changes in cerebral blood flow (CBF) which reflects
glucose metabolism and has been shown to be an indirect
marker of neural activity at the cell population level (Juepter and
Weiller 1995; Chen et al. 2008). After administering clozapine,
wt-hSyn-hM3Dq mice showed an increase in CBF around the
injection site (Fig. 1E,H). The increase was significantly higher
than in sham-operated mice (controls) scanned with identical
procedures for all time points up to 45 min (linear mixed model:
F2,21 =5.657, P=0.04; Fig. 1F,I). No changes in CBF were observed
in other brain regions, that is, the contralateral somatosensory
cortex and ipsilateral striatum (Fig. 1J,K). Together our electro-
physiological and CBF results show that activating the DREADDs
caused microcircuit excitation which was anatomically specific
to the injected area.
Activating hM3Dq-DREADD in wt-hSyn-hM3Dq Mice Decreases
Short-Range Connectivity Selectively Within Somatosensory and
Somatomotor Cortices
We next tested whether hM3Dq-DREADD also caused a local
disruption of functional connectivity (FC) measured with
rsfMRI. To this end, we calculated the regional homogene-
ity (ReHo) index, a commonly used metric to assess the
“synchronization” of BOLD fluctuations across neighboring
voxels. We chose ReHo because it has been shown to reflect
alterations occurring in various psychiatric diseases including
depression, schizophrenia, and autism (Paakki et al. 2010;
Iwabuchi et al. 2015). Activation of hM3Dq-DREADD significantly
reduced regional homogeneity only at the injection site when
compared with controls (blue cluster in Fig. 1L,M; P<0.05,
TFCE-corrected). These changes occurred within the first
15 min after clozapine injection and were maintained for the
whole scan period (Supplementary Figure 3A). No other area
exhibited similar changes. Note that the controls exhibited
a slight increase of ReHo after the clozapine injection. Since
the animals were only slightly anesthetized, it is likely that
they responded to the injection with an increase of general
arousal which has been shown to affect rsfMRI connectivity
(Zerbi, Floriou-Servou, et al. 2019a).
Activated DREADD in wt-hSyn-hM3Dq Mice Reduces Functional
Connectivity Between Somatosensory Cortex and Monosynaptically
Connected Cortical Areas
Does an increase in local microcircuit excitation also affect
long-range FC as quantified by correlating spontaneous BOLD
fluctuations between areas? To address this question, we
measured FC between 130 brain regions as identified by the
Allen Brain Reference Atlas Common Coordinate Framework
(CCFv3) at every 1-min interval (seeMethods).We then extracted
the effect size using the standardized difference between the
group means (Cohen’s d, wt-hSyn-hM3Dq vs. control mice)
between each pair of regions. During the first 15 min (baseline),
Cohen’s d varied on average between −0.2 and +0.2 (null-
to-small effect) and did not exhibit an appreciable spatial
or temporal pattern. However, immediately after clozapine
injection, we noticed a rapid reduction in FC between a number
of connections in the somatosensory and somatomotor cortices,
which remained hypoconnected for the whole scan session
(Fig. 2A,B).
We next quantified specific changes in FC within the
somatosensory network, that is, areas which are monosy-
naptically connected to the chemogenetic target, right SSp
according to the Allen Mouse Brain Connectivity Atlas (Oh et al.
2014). This anatomically defined network includes contralateral
primary SSp, bilateral somatomotor cortex (MO), ipsilateral
supplementary somatosensory cortex (SSs), bilateral association
areas (TEa), and ipsilateral caudoputamen (CP) (Fig. 2C). We
foundhigh FC between all of these structures at baseline (Fig. 2C)
and a strong structure–function correspondence (Fig. 2D). To
increase the power of our analysis, the BOLD time series of
the somatosensory network regions were binned into four
intervals of 15 min each. Pearson’s correlations were calculated
between regions and are summarized in FC matrices (Fig. 2E–
G and Supplementary Figure 4A). At baseline, FC did not show
differences between groups (Fig. 2E). By contrast, after clozapine
injection (Fig. 2F–H), we observed a reduction in FC between
right SSp and nearly all other areas of the network in wt-
hSyn-hM3Dqmice, including corticostriatal circuitry. Significant
group differences (permutation testing, P<0.05, FDR corrected)
were found between the right SSp and left SSp/left MO, as well
as between left and right MOp, and were maintained for the
duration of the scan session (Fig. 2H, Supplementary Figure 4B).
We also performed similar analyses in a small cohort of animals
using 1 mg/kg CNO which resulted in FC decrease within MO
regions in wt-hSyn-hM3Dq mice (Supplementary Figure 5).
We further complemented our analysis by assessing the
similarity between the BOLD time series of symmetric voxels in
the left and right hemispheres. This index has been shown to
identify pathological connectivity patterns with high sensitivity
as compared with other FC metrics (Hahamy et al. 2015). In line
with our previous findings, injecting clozapine caused a signif-
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Figure 1. Local changes in neural activity induced by activating hSyn-hM3Dq. (A) Neuronal firing rate before and after clozapine injection in the right SSp, indicating
a steady increase in firing rate upon DREADD activation. (B) As A but for the left SSp (control area) indicating no change in the neuronal firing rate after clozapine
injection. (C) Time-resolved firing rate in millisecond bins for the right (red) and left (black) SSp. A steady increase in firing rate occurs in the right SSp once clozapine
is injected, while no change occurs in the left SSp. (D) Relative change of averaged multiunit activity recorded in the right and left SSp. (E), (F) Cerebral blood flowmaps
were collected every 15 min for wt-hSyn-hM3Dq and control mice (displayed in their native space), respectively. (G) Clozapine is injected 15 min after the start of the
experiment. These 15 min are referred to as the baseline period (−15 to 0 min). The rest of the experiment is 45 min long and divided into three periods, that is, Post
1 (0–15 min), Post 2 (15–30 min), and Post 3 (30–45 min). For all analyses performed in this experiment (unless otherwise stated), Post data was expressed relative to
baseline (Post 1/Post 2/Post 3—baseline) and is referred to as 1, 2, and 3, respectively. (H) Comparison of blood flow (mL of blood/100 g/min) between controls and
wt-hSyn-hM3Dq mice over time (measured at the injection site). (I) Percentage change in blood flow over time between the controls (n=7) and wt-hSyn-hM3Dq (n=7)
mice (measured at the injection site). Linear mixed models indicate a significant main groups× scan time effect (F2,21 =5.657; P=0.04; asterisk indicates significant
between-group independent samples post hoc t-test at Post 1 (t12 =3.23; P=0.07), at Post 2 (t12 =2.66; P=0.02), and at Post 3 (t12 =2.35; P=0.04). (J) Percentage change in
blood flow over timemeasured in left SSp. (K) Percentage change in blood flow over timemeasured in the left lateral striatum. (L) Average regional homogeneity (ReHo)
change over time at the injection site. Repeatedmeasures ANOVA (control [n=13]; wt-hSyn-hM3Dq [n=14]) showed a significant groups× scan time effect (F1.93,75 =11.8;
P<0.001; asterisk indicates significant between-group independent samples post hoc t-test at Post 1 (t25 =−2.57; P=0.01), at Post 2 (t25 =−2.28; P=0.03), and at Post 3
(t25 =−2.1; P=0.05). (M) Significant decrease in ReHo in wt-hSyn-hM3Dqmice versus controls for 1 depicted as a 3D image and in coronal slices (TFCE-corrected). The
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Figure 2. Long-range connectivity changes induced by activating hSyn-hM3Dq. (A) Effect-size analysis (Cohen’s d) of functional connectivity is calculated for single
edges (n=844). Only cluster 1 shows a decrease in the effect size after clozapine injection. (B) Averaged effect size (Cohen’s d) over time for 20 edges of cluster 1 and 20
randomly selected edges of cluster 2. (C) Coronal brain slices depicting tracer data after unilateral injection in SSp (green, obtained fromAllenMouse Brain Connectivity
Atlas, Injection ID: 114290938) and averaged voxel-wise Pearson’s correlation (Fisher’s z-transform) during the baseline period from a seed in the right SSp. (D) Pearson’s
correlation between functional connectivity of the target region (right SSp) and tracer injection intensity obtained from images depicted in C. (E–G) Matrices represent
averaged and z-transformed Pearson’s correlation of all control animals (lower triangular matrix) and all wt-hSyn-hM3Dq animals (upper triangular matrix) for the
baseline period, Post 1 and Post 2, respectively. (H) The upper triangle of the matrix shows a reduction in FC in wt-hSyn-hM3Dq (n=14) mice compared with controls
(n=13) during 1 (i.e., Post 1-baseline), while the lower triangle shows the same set of comparisons in 2 (i.e., Post 2-baseline). Color coding reflects randomized
permutation testing, P<0.05, uncorrected. Asterisks indicate significant differences that survived FDR correction for multiple comparisons. MO, somatomotor cortex;
SSp-m, primary somatosensory cortex (mouth); SSs, supplementary somatosensory cortex; CP, caudoputamen; TEa, temporal association cortex; R, right; L, left. (I)
Change over time of the mean brain-wide VMHC (symmetric connectivity) at the injection site. Repeated measures ANOVA (controls [n=13]; wt-hSyn-hM3Dq [n=14])
indicates significant groups× scan time effect (F1.67,41.9 =21.18; P<0.001; asterisk indicates significant between-group independent samples post hoc t-test at Post 1
(t24 =−6.01; P=10
−5), at Post 2 (t24 =−5.93; P=10
−5), and at Post 3 (t24 =−5.22; P=10
−5). (J) Significant decrease (TFCE-corrected) in symmetric connectivity depicted on
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mice but not in controls which occurred only between the left
and right primary SSp and left and right MO (P<0.05; TFCE-
corrected) (Fig. 2I,J). In summary, our analyses demonstrate that
increasing local cortical excitation causes a reduction in local
connectivity that propagates into long-range FC reduction exclu-
sively within the targeted network.
Activated DREADD in wt-CAMK-hM3Dq Mice Reduces Functional
Connectivity
The above results were obtained using human synapsin-1 as the
promoter for the viral injection. Human synapsin-1 promoter
is not solely specific toward pyramidal neurons but can also
transfect inhibitory interneurons. To ensure specificity for pyra-
midal neurons,we repeated the above experiments in a separate
cohort of wild-type mice (n=13) using the CAMKII promoter for
AAV hM3Dq-DREADD delivery (Supplementary Figure 7). Firstly,
we measured CBF to confirm reliable DREADD activation at the
injection site. After administering clozapine, wt-CAMK-hM3Dq
mice showed a significant increase in CBF around the injection
site (Fig. 3A) as compared with controls (repeated measures
ANOVA: F(1.0, 20.0) = 7.3; P=0.004). This increase was limited
to the injection site and not observed in other brain regions
(Fig. 3B,C). Regional homogeneity as well as symmetric connec-
tivity metrics significantly decreased at the injection site after
DREADD activation in wt-CAMK-hM3Dq mice versus controls
(repeated measures ANOVA: F(1.3, 25.2) = 7.74, P=0.006; F(1.16,
21.98) = 8.21, P=0.007, respectively; Fig. 3D,E), and there was pro-
nounced underconnectivity within the somatosensory network
(Fig. 3F). Importantly, we replicated our results obtained with
human synapsin-1 promoter and confirmed that increasing
E:I by enhancing net excitatory synaptic transmission causes
a robust reduction of FC within an anatomically connected
network.
Changing E:I Balance by Inhibiting GABAergic Parvalbumin Neurons
Changes in E:I have been proposed as a principle mechanism
that underlies symptoms of neurodevelopmental disorders, irre-
spective of whether primarily excitatory or inhibitory synapses
are affected. Next, we tested whether suppressing the activity
of GABAergic PV interneurons—as reported in several mouse
models for ASD (Penagarikano et al. 2011;Wohr et al. 2015; Ajram
et al. 2017)—would cause similar macroscopic hypoconnectivity
as observed above. Nineteen Pvalbtm1(cre)Arbr (PVCre) were trans-
fected with an inhibitory hM4Di-DREADD. Clozapine activation
reduced PV cell activity which resulted in overexcitation of
right SSp but not a control region. Accordingly, the average
firing rate in right SSp went up by 20% following clozapine
injection (Fig. 4A,B and Supplementary Figure 6A,B), and local
cerebral blood flow increased moderately (repeated measures
ANOVA: F1.4,17.9 =2.45; P=0.1; Fig. 4C). Our rsfMRI analysis con-
firmed the expected reduction in local synchronization around
the injection site (Fig. 3D) and also marked underconnectivity
which wasmost pronounced between right and left SSp (Fig. 3E–
H) in PVCre-hSyn-hM4Di mice as compared with controls. In
summary, our results reveal that shifting E:I toward excitation by
inhibiting PV interneurons leads to a reduction of local and long-
range FC, which is qualitatively similar to that observed during
direct system excitation.
Altered E:I Balance Changes Local BOLD Dynamics
Our previous analyses demonstrated that increasing E:I in right
SSp affects its FC with other brain regions. We next aimed
to understand how microcircuit E:I shapes the fluctuations of
spontaneous BOLD regional activity. As depicted in Figure 4A,
we focused our analysis on three regions of interest: 1) right SSp
(the injection site); 2) left SSp (its homotopic counterpart); and
3) left visual cortex (a control region). The dynamics of BOLD
time series were characterized by an interdisciplinary library of
over 7000 features (using the software package hctsa (Fulcher
and Jones 2017)), which capture distinct properties of the BOLD
signal, including spectral power in different frequency bands,
temporal entropy, and many more (Fulcher et al. 2013; Fulcher
and Jones 2017; Sethi et al. 2017) (Fig. 5B; seeMethods for details).
Based on the change of these features from baseline to
activated DREADDs, we trained linear support-vector machine
(SVM) classifiers to distinguish: 1) wt-hSyn-hM3Dq versus con-
trols, 2) wt-CAMK-hM3Dq versus control, 3) PVCre-hM4Di ver-
sus controls, 4) wt-hSyn-hM3Dq versus wt-CAMK-hM3Dq, 5)
wt-CAMK-hM3Dq versus PVCre-hSyn-hM4Di, and 6) wt-hSyn
-hM3Dq versus PVCre-hSyn-hM4Di as shown in Figure 5C.
Our classification results reveal that BOLD dynamics of the
injected right SSp at 1 are differentiated from control mice
in wt-hSyn-hM3Dq (Fig. 5D), wt-CAMK-hM3Dq (Fig. 5E), and
PVCre-hSyn-hM4Di (Fig. 5F) with high accuracy (≥84% balanced
accuracy after 10-fold cross-validation), significantly exceeding
chance levels (P≤1×10−3, permutation test). Qualitatively
similar results were obtained at 2 (see Supplementary Results).
DREADD activation had a similarly large effect on the accuracy
of classifying BOLD dynamics in the left SSp but only for wt-
CAMK-hM3Dq (81%, P≤1×10−3), while for the other two groups,
the effect was much smaller—wt-hSyn-hM3Dq, 64% (P=0.1),
and PVCre-hSyn-hM4Di, 69% (P=0.03)—and finally the weakest
for the control region, VIS, in all groups wt-hSyn-hM3Dq, 43%
(P=0.7); wt-CAMK-hM3Dq, 45% (P=0.7); and PVCre-hSyn-hM4Di,
54% (P=0.3).
To aid visualization, we constructed principal component
projections of each dataset (including data at 2), shown for wt-
hSyn-hM3Dq versus control, wt-CAMK-hM3Dq versus control,
and PVCre-hSyn-hM4Di versus control in Figure 5H–J, respec-
tively. These plots reveal a clear distinction between DREADD-
activated and control mice on the basis of their BOLD dynamics
in right SSp.
We next sought to investigate the properties of BOLD time
series between the three DREADD manipulated groups at the
right SSp during 1. As shown in Figure 5G, BOLD dynamics at
the right SSp between wt-hSyn-hM3Dq and wt-CAMK-hM3Dq
are clearly distinct (75% balanced accuracy, P=0.01). BOLD
dynamics between wt-hSyn-hM3Dq and PVCre-hSyn-hM4Di
and wt-CAMK-hM3Dq and PVCre-hSyn-hM4Di, in the right SSp,
are not significantly distinguishable (63% balanced accuracy,
P=0.09, and 62% balanced accuracy, P=0.1, respectively).
Moreover, the clear discrimination of BOLD dynamics in
principal components space ismainly absent (visible as strongly
overlapping distributions in Fig. 5K). Properties of BOLD time
series were also unable to significantly distinguish DREADD
manipulations in left SSp and visual control region during 1
(Supplementary Figure 9A,B).
Since wt-hSyn-hM3Dq and PVCre-hSyn-hM4Di increase
E:I through different mechanisms, we next sought to further
compare the effect of their manipulations on BOLD dynamics;
we computed a similarity measure between changes in BOLD
time-series properties caused by both manipulations relative
to controls (as a Spearman’s ρ in right SSp and left SSp
relative to the control region across all time-series features;
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Figure 3. Changes induced by activating CAMK-hM3Dq in wild-type mice. (A) Comparison of blood flow (mL of blood/100 g/min) over time between controls and
wild-type mice injected with excitatory (hM3Di) DREADD on CAMKII promoter (measured at the injection site). We observe a significant repeated measures ANOVA
groups× scan time effect (F(1.0, 20.0) = 7.3; P=0.004; asterisk indicates significant between-group independent samples post hoc t-test at Post 1 (t9.8 =2.7; P=0.02) and
at Post 2 (t9.4 =2.1; P=0.05) in blood flow in wt-CAMK-hM3Dq mice (n=13) after clozapine injection (similar to wt-hSyn-hM3Dq from Fig. 2H). (B,C) Blood flow in the
left SSp and left CP does not significantly differ between controls and wt-CAMK-hM3Dqmice. (D) Change over time of mean regional homogeneity at the injection site
(right SSp). There is a significant decrease (repeated measures ANOVA significant groups× scan time effect: F(1.3, 25.2) = 7.74, P=0.006; asterisk indicates significant
between-group independent samples post hoc t-test at Post 1 [t23 =−3.46; P=0.002] and at Post 2 [t23 =−3.49; P=0.002]) in mean connectivity in wt-CAMK-hM3Dq
(n=13) mice as compared with controls (n=13). (E) Change over time of mean symmetric connectivity at the injection site. There is a significant decrease (repeated
measures ANOVA groups× scan time effect: F(1.16, 21.98) = 8.21, P=0.007; asterisk indicates significant between-group independent samples post hoc t-test at Post 1
(t24 =3.85; P=0.001) and at Post 2 [t24 =4.26; P=10
−5]) in mean connectivity in wt-CAMK-hM3Dq (n=13) mice as compared with controls (n=13). (F) Matrix represents
statistically significant differences during 1 and 2 time period among three brain regions (MO, somatomotor cortex; SSp, somatosensory cortex; SSs, supplementary
somatosensory cortex; R, right; L, left) between the controls and wt-CAMK-hM3Dq mice. The asterisk within ROIs indicates a statistically significant difference that
survived correction of multiple comparisons.
between wt-hSyn-hM3Dq and PVCre-hSyn-hM4Di in right SSp
(ρ =0.59) and left SSp (ρ =0.47), suggesting that the temporal
properties of BOLD dynamics are more sensitive to the net
overexcitation common to both DREADD cohorts than to the
underlying synaptic transmission pathway within the cortical
microcircuit (see Supplementary Material for an analysis of
BOLD time-series features that are individually informative
of E:I).
Fmr1y/− Exhibit Similar Local BOLD Dynamics
to DREADD-Manipulated Mice
Our previous analysis yielded a classifier for predicting an acute
microcircuit E:I increase from macroscopic BOLD dynamics.
Next, we asked whether such a classifier can also detect
abnormal BOLD dynamics in a transgenic disease model of
ASD. We used rsfMRI data from Fmr1y/− knockout mice that
mimic fragile X syndrome, a neurodevelopmental disorder
characterized by cognitive impairment, epileptic seizures,
physical abnormalities, and hypersensitivity. Previous studies
in Fmr1y/− mice report a reduction in cortical PV cell density,
specifically within somatosensory region, followed by cortical
hyperexcitability (Selby et al. 2007; Gibson et al. 2008; Wohr
et al. 2015; Nomura et al. 2017). These findings indicate that the
diseasemechanismof Fmr1y/− mice affects the net excitability of
cortical microcircuits in a similar manner as chemogenetically
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Figure 4. Changes induced by activating hSyn-hM4Di in PVCre mice. (A) Neuronal firing rate at the right SSp DREADD injection site of the PVCre-hSyn-hM4Di mice
before and after clozapine injection, indicating a steady increase in firing rate on DREADD activation. (B) Similar to figure A but for right caudoputamen, indicating
no change in the neuronal firing rate after clozapine injection. (C) Comparison of blood flow (mL of blood/100 g/min) between controls (n=7) and PVCre-hSyn-hM4Di
(n=13) mice over time (measured at the injection site). No significant differences observed between groups (repeated measures ANOVA: F1.4,17.9 =2.45; P=0.1). (D)
Normalized average regional homogeneity (ReHo) change over time at the injection site. Repeated measures ANOVA indicates significant groups× scan time effect:
F1,25 =14.01; P=0.001; asterisk indicates significant between-group independent samples post hoc t-test at 1 (t30 =−4.17; P=10
−5) and at 2 (t30 =−7.15; P=10
−6). (E)
Normalized averaged symmetric connectivity over time at the injection site. Repeated measures ANOVA indicates significant groups× scan time effect: F1.2, 21.9 =8.21;
P=0.007; asterisk indicates significant between-group independent samples post hoc t-test at 1 (t29 =−3.52; P=0.001) and at 2 (t29 =−5.78; P=10
−5). (F) Seed-to-seed
analysis indicates reduced FC (randomized permutation testing, P<0.05, uncorrected) between controls (n=13) and PVCre-hSyn-hM4Di (n=19) mice. (G,H) Whole-brain
connectome analysis shows a significant interhemispheric reduction between somatosensory cortices for 1 and 2 between PVCre-hSyn-hM4Di (n=14) mice and
controls (n=13). Regions affected are as follows: SSp-m, primary somatosensory area, mouth; SSp-ul, primary somatosensory area, upper limb; SSs, supplementary
somatosensory area; SSp-bdf, primary somatosensory area, barel field; SSp-n, primary somatosensory area, nose.
circuit-level alterations cause analogous alteration of macro-
scopic rsfMRI dynamics. To test this hypothesis, we trained a
classifier for PVCre-hSyn-hM4Di rsfMRI time series in the right
SSp during 1 as above (Figs 4E and 5A). We then applied this
classifier to rsfMRI data from 46 cortical ROIs (23 from each
hemisphere) in Fmr1y/− mice (n=44) and wild-type littermates
(Fmr1y/+, n=39) and assigned predicted labels to each brain
region of Fmr1y/− and Fmr1y/+ independently (Fig. 5B). As shown
in Figure 5C, regional BOLD dynamics of Fmr1y/− versus wild-
type controls could be significantly classified in 10 different
areas of the right hemisphere (balanced classification accuracy,
P< 0.05, FDR-corrected) using a classifier trained on PVCre-
hSyn-hM4Di data. Corresponding to the brain area in which the
DREADDs classifier was trained, regions of the SSp displayed
the highest classifiability. Similar results were obtained in the
left hemisphere, resulting in a Spearman’s ρ =0.69 (P=3× 10−4)
between the left and right hemispheres (Fig. 5E,F). We next
tested whether regional variation in classification accuracy
was related to differences in PV cell density using data from
qBrain (Kim CK et al. 2017a). As shown in Figure 6D, classification
accuracy is only weakly correlated with PV cell density, ρ =0.33
(P=0.1), but is highest in SSp regions with the highest PV
cell density (dark green in Fig. 6D). Interestingly, the classifier
identified several prefrontal areas (bright green in Fig. 6D) which
exhibited abnormal rsfMRI dynamics according to the classifier
despite low PV cell density. This finding is in line with former
reports of abnormal prefrontal cortex function in Fmr1y/− mice
(Paul et al. 2013; Routh et al. 2017). Our results demonstrate that
a classifier trained on a controlled chemogenetic manipulation
causing an acute shift of the E:I balance is generalizable to
Fmr1y/−, indicating a strong degree of similarity between cortical
BOLD dynamics resulting from PVCre-hSyn-hM4Di and Fmr1y/−
knockout.
Discussion
It has been a long-standing question how disease mechanisms
at the cellular level map onto abnormal dynamics at the
level of macroscopic brain networks. Here we show in three
independent cohorts that acutely increasing the microcircuit
E:I balance in somatosensory cortex via chemogenetics causes
distinct changes of macroscopic brain dynamics and severe
functional underconnectivity between the manipulated region
of interest (SSp) and monosynaptically connected brain areas.
These macroscopic changes were observed irrespective of
whether we enhanced excitatory transmission or selectively
suppressed inhibitory PV neurons of the same cortical circuits.
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Figure 5.DREADDmanipulations lead to characteristic changes in univariate BOLDdynamics.Classification of BOLD signal dynamics in three brain regions (the injected
right SSp, left SSp, and VIS) across four conditions (wt-hSyn-hM3Dq, wt-CAMK-hM3Dq PVCre-hSyn-hM4Di, and control). A schematic of the approach is depicted in
A–C: (A) BOLD dynamics are measured from each brain region as a univariate time series (a 15-min time series per time window and experiment), which was (B)
converted to a set of properties (a “feature vector”) using hctsa. (C) For a given region and pair of classes, we used the features of each time series (relative to baseline)
as the basis for classification, which was visualized using a low-dimensional principal component projection and quantified as the 10-fold cross-validated balanced
classification accuracy (%). Classification results in each brain region at 1 are shown for (D) wt-hSyn-hM3Dq (n=14) versus control (n=13), (E) wt-CAMK-hM3Dq
(n=13) versus control (n=13), and (F) PVCre-hSyn-hM4Di (n=10) versus control (n=13), revealing significant discriminability in the right SSp for wt-hSyn-hM3Dq and
PVCre-hSyn-hM4Di versus control (permutation test, P<0.05, annotated as “∗”). There is a consistent trend of high discriminability in the injected region (right SSp),
followed by the contralateral region (left SSp), and lowest discriminability in the control region (VIS). (G) Classification results in the right SSp at 1 are shown for
wt-hSyn-hM3Dq versus wt-CAMK-hM4Di, wt-hSyn-hM3Dq versus PVCre-hSyn-hM4Di, and wt-CAMK-hM4Di versus PVCre-hSyn-hM4Di. High discriminability is only
present for wt-hSyn-hM3Dq versus wt-CAMK-hM4Di (permutation test, P<0.05, annotated as “∗”). BOLD time series in right SSp are visualized in two-dimensional
principal component spaces in (H–K) for the same three pairs of classes as in (D–G). Time series with similar properties are close in the space, revealing a visual
depiction of the discriminability of wt-hSyn-hM3Dq, wt-CAMK-hM3Dq, and PVCre-hSyn-hM4Di relative to control (H–J), but a relative lack of discriminability in K.
Shaded ellipses (1) have been added to guide the eye, and time series from each class are labeled for 1 and 2.
BOLD dynamics reflect the state of underlying cortical microcir-
cuits. Furthermore, we show that different cellular mechanisms
can cause common pathophysiological abnormalities and
converge on highly similar alterations of neural dynamics at
the network level. In particular, upon activating the DREADDs,
there was a marked reduction of FC which was temporally
locked to our stimulation paradigm and spatially specific to the
injected area and its monosynaptically connected neighbors.
Reduced FC has been frequently reported in human fMRI
studies of neurodevelopmental disorders, such as autism and
schizophrenia (Uhlhaas and Singer 2006; Minshew and Keller
2010; Gao and Penzes 2016; Kraguljac et al. 2016; Wang et al.
2018), as well as in relevant mouse models of these disorders
(CNTNAP2, Fmr1y/−, En2) (Bertero et al. 2018; Zerbi et al. 2018).
Many of these mouse models have been shown to exhibit an
increased E:I (Rubenstein and Merzenich 2003; Gibson et al.
2008; Contractor et al. 2015). Additionally, they suffer from
reduced PV interneuron expression (Penagarikano et al. 2011;
Vogt et al. 2017). Depletion of this specific cell type has been
hypothesized to cause aberrant patterns of neural activity and
connectivity (Penagarikano et al. 2011; Wohr et al. 2015), as
fast-spiking PV interneurons target the proximal regions of
pyramidal cells (Hu et al. 2014; Safari et al. 2017) and synchronize
firing within pyramidal cell populations (Engel and Singer 2001;
Bartos et al. 2007; Cardin et al. 2009; Sohal et al. 2009; Roux and
Buzsaki 2015; Cardin 2018). This hypothesis has been recently
confirmed byMarissal and colleagues,who found that DREADD-
induced suppression of PV activity causes the disinhibition
of pyramidal neurons and leads to mass desynchronization
of spiking activity (Marissal et al. 2018). Congruent with
these previous empirical findings and recent theoretical
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Figure 6. Fmr1y/− exhibit similar local BOLD dynamics as DREADD-manipulated mice. (A) The classifier was trained on features of right SSp BOLD time series to
distinguish PVCre-hSyn-hM4Di from control mice. (B) The trained classifier was used to predict the identity of cortical BOLD time series measured from Fmr1y/−
(knockout) and Fmr1y/+ (control) mice, identifying predictions of PVCre-hSyn-hM4Di as Fmr1y/− . Predictability in each brain region was assessed as balanced
classification accuracy (%); P values were estimated using a permutation test. (C) Classification results are shown for the right hemisphere, highlighting regions
with significant classification accuracy (P<0.05, FDR-corrected) as bold, dark green, andmarked with asterisks. (D) Scatter plot of balanced classification accuracy and
PV cell density. (E) Balanced classification accuracy is plotted for each region in the right and left hemispheres, exhibiting a strong positive correlation, Spearman’s
ρ =0.69 (P=3× 10−4). (F) Balanced classification accuracy visualized on a 3D brain.
neurons reduces the synchronization of neuronal ensembles
as indicated by the reduction of FC, despite higher net cortical
activity.
Interactions among different types of neurons within
a microcircuit should be balanced for proper functioning.
Lee and colleagues (Lee et al. 2018) have recently built a
computational model of the sensory cortex microcircuit and
demonstrated the importance of connectivity homeostasis
between neuronal types (i.e., inhibitory and excitatory cells) for
producing synchronized oscillatory behavior with maximum
frequency tuning capacity. Any deviation from this optimal
configuration, such as overexcitation of pyramidal neurons,
breaks this synchrony and impairs the communication among
neuronal ensembles, which at the macroscale may be perceived
as a reduction in FC. In line with this theoretical framework,
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activate pyramidal neurons.We replicated this principle finding
across three independent cohorts, using either clozapine or CNO
to activate the DREADDs (see Supplementary Discussion) and
using either human synapsin (hSyn) or CAMKII as a promoter
in the AAV constructs. While hSyn promoter is active in both
excitatory and inhibitory neurons, CAMKII generates a clear
bias toward gene expression in excitatory cortical neurons (up
to 85%) even though it might also transfect a small number of
inhibitory neurons. Importantly, our electrophysiological results
confirmed that activating excitatory DREADDs in the wt-hSyn-
hM3Dq mice caused a significant net increase of neuronal
firing rate, and our CBF measurements confirmed that such
an increase was anatomically specific and most pronounced
within the targeted SSp. Activating the excitatory DREADDs
caused overall a stronger reduction of FC in wt-hSyn-hM3Dq
mice than in PVCre-hM4Di mice, which might result from a
higher number of transfected neurons: mouse cortex contains
12% GABAergic neurons, of which approximately one-quarter
are PV (Feldmeyer et al. 2018) resulting in a rather low absolute
number of transfected neurons and smaller DREADD-induced
effects (Grayson et al. 2016).
Our results also characterize a potential role of local E:I bal-
ance in shaping the BOLD dynamics of individual brain regions.
Specifically, we showed that the chemogenetic manipulation of
the cellular excitability causes specific changes of local BOLD
features that we could distinguish from neurotypical BOLD
dynamics with high accuracy (balanced accuracy >80%) and
anatomical specificity, irrespective of whether we increased
excitatory transmission (wt-hSyn-hM3Dq andwt-CAMK-hM3Dq
cohort) or suppressed inhibition (PVCre-hSyn-hM4Di cohort). In
a cohort of wt-CAMK-hM3Dq mice, we detected BOLD dynamics
with a high accuracy in the contralateral left SSp; this could be
due to DREADD-transfected transcallosal excitatory neurons.
Moreover, high classification accuracy was also observed in
the dynamics of the right SSp between the two excitatory
DREADD cohorts (wt-hSyn-hM3Dq and wt-CAMK-hM3Dq). This
difference can be attributed to the two promoters and their
distinct transfection affinities toward excitatory and inhibitory
neurons.
The E:I BOLD signature learned from acutely modulating
cell activity could be detected in two independent cohorts
of Fmr1y/− mice, a well-characterized mouse model of ASD.
We chose Fmr1y/− mice for external validation because they
are known to have deficits in local feedback inhibition due to
reduced PV interneuron density (Selby et al. 2007; Cea-Del Rio
and Huntsman 2014). This leads to increased excitability and
decreased synchrony of pyramidal cell firing through gamma
oscillations (Gibson et al. 2008; Wohr et al. 2015) as well as
substantially reduced FC in corticocortical and corticostriatal
circuits (Zerbi et al. 2018; Zerbi et al. 2019b). Interestingly, above
chance-level detection accuracies of BOLD dynamics charac-
terizing overexcitation in Fmr1y/− mice were found in regions
which normally exhibit high PV cell densities (Selby et al. 2007)
providing further indirect evidence that the specific features
of abnormal BOLD dynamics are related to the depletion of PV
neurons in this mouse model. Fmr1y/− mice exhibit depletion of
PV interneurons resulting in chronic overexcitation of the cor-
tex, while PV interneurons in our PVCre-hSyn-hM4Di mice were
only acutely manipulated. Despite these differences between
the two models, we observed high classification accuracies in
distinguishing Fmr1y/− mice from a statistical model trained on
the PVCre DREADDmanipulation. This correspondence strongly
suggests that both acute and chronic overexcitation caused by
PV depletion or inhibition share a common BOLD dynamical
signature.
Our findings demonstrate that a chemogenetically inspired
and experimentally validated classifier can be used as a compu-
tational sensor which uses BOLD dynamics to infer whether a
specific brain area exhibits increased microcircuit E:I, for exam-
ple, due to abnormal PV neuron activity.
It is unclear whether this discovery is generalizable to the
entire cortex since changes in microstructural properties such
as cytoarchitecture, E:I, size, density, and laminar distribution of
distinct cell types vary continuously throughmouse cortex (Kim
Y et al. 2017b; Fulcher et al. 2019). These variations in spatial
gradients shape functional specialization along the cortex and
influence the intrinsic time scale that can be measured in
BOLD dynamics in different cortical areas (Sethi et al. 2017).
Nevertheless,we show above chance-level detection accuracy in
the prefrontal cortex of Fmr1y/− mice that are also attributed to
an increased E:I balance from previous studies (Paul et al. 2013).
These results provide a new framework for mechanistically
linking microscale circuit dynamics to macroscopic fMRI-
based brain activity at rest. Thus far, this approach is unique
because it uses causal microcircuit alterations to train a
classifier that can detect similar alterations from distinct
datasets obtained from large-scale imaging techniques. Our
framework goes beyond describing long-range connectional
aberrations caused by neurodevelopmental disorders and aims
at providing deeper insights into how distinct microcircuit
dynamics relate to large-scale, noninvasive imaging mea-
surements which can be obtained across different species,
including in human patients. Better linking macroscopic
alteration to the underlying neurobiology is a prerequisite for
advancing neuroimaging as a tool in the context of clinical
decision-making.
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Supplementary material can be found at Cerebral Cortex online.
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